We are live on ! Find out more
FC

FORA Capital Portfolio holdings

AUM $1.46B
1-Year Est. Return 64.79%
This Fund
S&P 500
This Quarter Est. Return
+29.06%
1 Year Est. Return
+64.79%
3 Year Est. Return
+161.8%
5 Year Est. Return
+205.45%
10 Year Est. Return
AUM
$1.46B
AUM Growth
+$91.8M
Cap. Flow
+$34.5M
Cap. Flow %
2.37%
Top 10 Hldgs %
16.73%
Holding
583
New
170
Increased
97
Reduced
78
Closed
238

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$39.8M
2
BSX icon
Boston Scientific
BSX
+$20.9M
3
META icon
Meta Platforms (Facebook)
META
+$20.6M
4
ROST icon
Ross Stores
ROST
+$19.7M
5
CSCO icon
Cisco
CSCO
+$19.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$23.2M
2
VZ icon
Verizon
VZ
+$22M
3
MSFT icon
Microsoft
MSFT
+$19.8M
4
CMI icon
Cummins
CMI
+$19.7M
5
CAT icon
Caterpillar
CAT
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 35.44%
2 Industrials 11.01%
3 Financials 10.69%
4 Consumer Discretionary 9.75%
5 Healthcare 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
176
Acuity Brands
AYI
$9.81B
$1.65M 0.11%
4,369
-7,950
-65% -$2.36M
AMG icon
177
Affiliated Managers Group
AMG
$9.34B
$1.61M 0.11%
4,760
-9,118
-66% -$2.83M
HGV icon
178
Hilton Grand Vacations
HGV
$3.2B
$1.59M 0.11%
+30,377
New +$1.47M
ALNY icon
179
Alnylam Pharmaceuticals
ALNY
$34.9B
$1.57M 0.11%
5,209
+738
+17% +$223K
ABVX
180
Abivax
ABVX
$10.4B
$1.57M 0.11%
11,758
-1,428
-11% -$162K
ROIV icon
181
Roivant Sciences
ROIV
$30.4B
$1.56M 0.11%
44,129
-9,280
-17% -$274K
AXSM icon
182
Axsome Therapeutics
AXSM
$10.9B
$1.56M 0.11%
6,364
+4,914
+339% +$1.07M
TVTX icon
183
Travere Therapeutics
TVTX
$6.21B
$1.55M 0.11%
+27,289
New +$1.21M
CHEF icon
184
Chefs' Warehouse
CHEF
$4.56B
$1.52M 0.1%
+15,800
New +$1.22M
ESTC icon
185
Elastic
ESTC
$9.48B
$1.49M 0.1%
26,078
-4,108
-14% -$220K
HAS icon
186
Hasbro
HAS
$12.8B
$1.48M 0.1%
+17,943
New +$1.61M
SMR icon
187
NuScale Power
SMR
$4.6B
$1.48M 0.1%
147,269
+135,395
+1,140% +$1.53M
LQDA icon
188
Liquidia Corp
LQDA
$6.12B
$1.47M 0.1%
+18,457
New +$989K
RL icon
189
Ralph Lauren
RL
$20.9B
$1.45M 0.1%
+3,619
New +$1.35M
CLSK icon
190
CleanSpark
CLSK
$3.44B
$1.45M 0.1%
+99,690
New +$1.41M
VSXY
191
Victoria's Secret
VSXY
$6.19B
$1.44M 0.1%
17,267
-27,511
-61% -$1.65M
DPZ icon
192
Domino's
DPZ
$11.2B
$1.43M 0.1%
+4,823
New +$1.59M
PRAX icon
193
Praxis Precision Medicines
PRAX
$9.89B
$1.41M 0.1%
4,205
+793
+23% +$251K
APTV icon
194
Aptiv
APTV
$9.51B
$1.39M 0.1%
22,701
+18,368
+424% +$1.12M
VIK icon
195
Viking Holdings
VIK
$38.6B
$1.39M 0.1%
+13,235
New +$1.15M
MYRG icon
196
MYR Group
MYRG
$4.56B
$1.35M 0.09%
+2,688
New +$1.1M
REGN icon
197
Regeneron Pharmaceuticals
REGN
$83.7B
$1.34M 0.09%
+2,147
New +$1.46M
JAZZ icon
198
Jazz Pharmaceuticals
JAZZ
$15.7B
$1.3M 0.09%
+5,408
New +$1.18M
IESC icon
199
IES Holdings
IESC
$13.7B
$1.3M 0.09%
+3,550
New +$1.15M
EXEL icon
200
Exelixis
EXEL
$14.6B
$1.26M 0.09%
+23,067
New +$1.12M

Similar funds

FORA Capital's Q2 2026 Portfolio in Review

As of Q2 2026, FORA Capital held 583 positions worth $1.46B, up 6.7% from $1.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

FORA Capital's Q2 2026 filing shows 170 new, 97 increased, 78 reduced and 238 closed positions. Its largest new stake was Intuit: 114,377 shares worth $29.8M. The largest sale was Oracle, an estimated $23.2M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.

  • FORA Capital's largest Q2 2026 buy was Intuit: 114,377 shares worth $29.8M.
  • FORA Capital added most to Boston Scientific in Q2 2026, an estimated $20.9M increase.
  • FORA Capital's biggest Q2 2026 reduction was Microsoft, cutting an estimated $19.8M.
  • FORA Capital fully exited Oracle in Q2 2026, selling an estimated $23.2M.
  • FORA Capital's ten largest holdings make up 17% of its $1.46B portfolio in Q2 2026.
  • FORA Capital opened 170 new positions and closed 238 in Q2 2026.
  • FORA Capital's portfolio value rose 6.7% quarter-over-quarter to $1.46B.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.